-
1
المؤلفون: Jiten Vora, Jason Gordon, Iskandar Idris, Carl Tilling
المصدر: Journal of Medical Economics. 18:273-282
مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Insulin, Isophane, Insulin Glargine, NPH insulin, Comorbidity, Type 2 diabetes, Body Mass Index, Internal medicine, Diabetes mellitus, Outcome Assessment, Health Care, medicine, Electronic Health Records, Humans, Hypoglycemic Agents, In patient, Propensity Score, Glycated Hemoglobin, business.industry, Health Policy, Insulin, Body Weight, Health Care Costs, Middle Aged, medicine.disease, Obesity, Hypoglycemia, United Kingdom, Insulin, Long-Acting, Endocrinology, Diabetes Mellitus, Type 2, Multivariate Analysis, Propensity score matching, Costs and Cost Analysis, Female, Analysis of variance, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad399551e5aede3c5e076c2e2ddcceb3Test
https://doi.org/10.3111/13696998.2014.991788Test -
2
المؤلفون: Ursula Benter, Michael L. Volk, Lusine Breitscheidel, Oliver Schöffski, Franz-Werner Dippel, Markus Muller, Martin Pfohl
المصدر: Journal of Medical Economics. 11:695-712
مصطلحات موضوعية: Male, Pediatrics, medicine.medical_specialty, medicine.medical_treatment, Insulin Glargine, NPH insulin, Type 2 diabetes, Drug Costs, Germany, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, Aged, business.industry, Insulin glargine, Health Policy, Type 2 Diabetes Mellitus, Middle Aged, medicine.disease, Surgery, Insulin, Long-Acting, Diabetes Mellitus, Type 2, Cohort, Health Resources, Female, Observational study, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d92448f0a0e68eeb54898838443663aTest
https://doi.org/10.3111/13696990802645726Test -
3
المؤلفون: Jayne Smith-Palmer, William J. Valentine, Åsa Ericsson, Richard F Pollock, C. Fajardo-Montañana
المصدر: Journal of medical economics. 15(5)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Pediatrics, Cost effectiveness, medicine.medical_treatment, Cost-Benefit Analysis, Insulin, Isophane, NPH insulin, Type 2 diabetes, law.invention, Randomized controlled trial, Insulin Detemir, law, Internal medicine, Outcome Assessment, Health Care, medicine, Humans, Hypoglycemic Agents, Insulin detemir, Aged, Randomized Controlled Trials as Topic, Sweden, business.industry, Health Policy, Insulin, Middle Aged, Models, Theoretical, medicine.disease, Insulin, Long-Acting, Endocrinology, Treatment Outcome, Diabetes Mellitus, Type 2, Female, Quality-Adjusted Life Years, medicine.symptom, business, Body mass index, Weight gain, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c4922df4acaa08c9a4a015e1aa1e17Test
https://pubmed.ncbi.nlm.nih.gov/22563742Test -
4
المؤلفون: Andreas Ericsson, O. Torfvitt, Martin Ridderstråle, Johan Jendle, S. Larsen
المصدر: Journal of medical economics. 15(2)
مصطلحات موضوعية: medicine.medical_specialty, Financing, Personal, endocrine system diseases, medicine.medical_treatment, Insulin, Isophane, NPH insulin, Type 2 diabetes, Hypoglycemia, Willingness to pay, Insulin Detemir, Internal medicine, Diabetes mellitus, Outcome Assessment, Health Care, medicine, Humans, Hypoglycemic Agents, Insulin detemir, Sweden, business.industry, Health Policy, Insulin, nutritional and metabolic diseases, Patient Preference, medicine.disease, Proxy, Insulin, Long-Acting, Endocrinology, Diabetes Mellitus, Type 2, medicine.symptom, business, Weight gain, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e098e044bc4457d27d7ac20a53808d8aTest
https://pubmed.ncbi.nlm.nih.gov/22142237Test